About GenoPalate
GenoPalate is a company based in Milwaukee (United States) founded in 2016 by Sherry Zhang. GenoPalate has raised $15.66 million across 9 funding rounds from investors including Gener8tor and BrightStar Wisconsin Foundation. GenoPalate operates in a competitive market with competitors including Viome, Invitae, Color, Everlywell and Variant Bio, among others.
- Headquarter Milwaukee, United States
- Founders Sherry Zhang
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$15.66 M (USD)
in 9 rounds
-
Latest Funding Round
$250 K (USD), Series A
Feb 09, 2026
-
Investors
Gener8tor
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of GenoPalate
Unlock access to complete
Product Management Team
1 people
Software Development Team
1 people
Data Analysis and Operations Team
1 people
Unlock access to complete
Funding Insights of GenoPalate
GenoPalate has successfully raised a total of $15.66M across 9 strategic funding rounds. The most recent funding activity was a Series A round of $250 thousand completed in February 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in GenoPalate
GenoPalate has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Gener8tor and BrightStar Wisconsin Foundation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Startups are accelerated via a 12-week program with funding support.
|
Locked | Locked | Locked | |
|
Capital is provided to Wisconsin entrepreneurs for job creation.
|
Locked | Locked | Locked |
Investor details for GenoPalate
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by GenoPalate
Investment portfolio details for GenoPalate
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - GenoPalate
Detailed financials for GenoPalate
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Genopalate Comparisons
Peer comparison for GenoPalate
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of GenoPalate
GenoPalate operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Viome, Invitae, Color, Everlywell and Variant Bio, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Machine learning-based bioinformatics solutions for health insights are provided.
|
|
| Locked | Locked | Locked |
Home-based genetic tests for detecting diseases are provided to individuals.
|
|
| Locked | Locked | Locked |
Cancer care is delivered through a virtual clinic by Color.
|
|
| Locked | Locked | Locked |
At-home health tests for biomarkers, nutrition, and hormone analysis.
|
|
| Locked | Locked | Locked |
Personalized therapeutics are developed using genomic data for rare diseases.
|
|
| Locked | Locked | Locked |
Health management platform is provided for employers and insurers.
|
Detailed competitors of GenoPalate
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Genopalate
Complete news archive for GenoPalate
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about GenoPalate
GenoPalate was founded in 2016 and raised its 1st funding round 1 year after it was founded.
GenoPalate is headquartered in Milwaukee, United States. It is registered at Milwaukee, Wisconsin, United States.
Sherry Zhang is the current CEO of GenoPalate. They have also founded this company.
GenoPalate is a funded company, having raised a total of $15.66M across 9 funding rounds to date.
GenoPalate was founded in 2016 in Milwaukee, United States, and operates in the personalized nutrition sector. DNA test kits are provided for sample collection, which are analyzed using a proprietary algorithm. Reports with diet and food recommendations are generated from the results. A customized toolkit containing nutritional information and advice is supplied to consumers for ongoing use.
GenoPalate's top competitors include Viome, Variant Bio and Segterra (InsideTracker).
GenoPalate has 2 investors. Key investors include Gener8tor, and BrightStar Wisconsin Foundation.